These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23785226)

  • 21. Evaluating a restrictive formulary system by assessing nonformulary-drug requests.
    Green JA; Chawla AK; Fong PA
    Am J Hosp Pharm; 1985 Jul; 42(7):1537-41. PubMed ID: 4025350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The application of adverse drug reaction data to drug choice decisions made by pharmacy and therapeutics committees. An Australian perspective.
    Weekes LM; Day RO
    Drug Saf; 1998 Mar; 18(3):153-9. PubMed ID: 9530535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Access to new cardiovascular therapies in Canadian hospitals: a national survey of the formulary process.
    Shalansky SJ; Virk R; Ackman M; Jackevicius C; Kertland H; Tsuyuki R; Humphries K;
    Can J Cardiol; 2003 Feb; 19(2):173-9. PubMed ID: 12601443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Institutional formularies: the relevance of pharmacoeconomic analysis to formulary decisions.
    Lipsy RJ
    Pharmacoeconomics; 1992 Apr; 1(4):265-81. PubMed ID: 10147017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of Nonformulary Medication Approvals in an Academic Medical Center.
    Her QL; Amato MG; Seger DL; Gilmore JF; Fanikos J; Fiskio JM; Bates DW
    Jt Comm J Qual Patient Saf; 2017 Feb; 43(2):89-96. PubMed ID: 28334567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals.
    Mannebach MA; Ascione FJ; Gaither CA; Bagozzi RP; Cohen IA; Ryan ML
    Am J Health Syst Pharm; 1999 Apr; 56(7):622-8. PubMed ID: 10423208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Academy of Managed Care Pharmacy Format for Formulary Submissions: an evolving standard--a Foundation for Managed Care Pharmacy Task Force report.
    Fry RN; Avey SG; Sullivan SD
    Value Health; 2003; 6(5):505-21. PubMed ID: 14627057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survey of formulary system policies and procedures.
    Rascati KL
    Am J Hosp Pharm; 1992 Jan; 49(1):100-3. PubMed ID: 1570847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishing an enteral product formulary.
    Ford DB; Bergerson SL; Henderson P; Murphy J; Peter J
    J Am Diet Assoc; 1989 May; 89(5):681-3. PubMed ID: 2498416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insights on developing a field hospital formulary and medication distribution process in preparation for a second surge of COVID-19 cases.
    Bazzell B; Wagner D; Durant KM; Callahan B
    Am J Health Syst Pharm; 2020 Oct; 77(21):1763-1770. PubMed ID: 32705115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial formulary management: meeting the challenge in a health maintenance organization.
    Carlson JA
    Pharmacotherapy; 1991; 11(1 ( Pt 2)):32S-35S. PubMed ID: 2011571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of Hospital Formularies in Ontario: Challenges within a Local Health Integration Network.
    Burke N; Bowen JM; Troyan S; Jegathisawaran J; Gosse C; Tonkin M; Kagoma S; Goeree R; Holbrook A
    Can J Hosp Pharm; 2016; 69(3):187-93. PubMed ID: 27402997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies for deleting popular drugs from a hospital formulary.
    Lemay AP; Salzer LB; Visconti JA; Latiolais CJ
    Am J Hosp Pharm; 1981 Apr; 38(4):506-10. PubMed ID: 7282675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulary streamlining through therapeutic class review.
    Guerriero SE; Neff JL
    Hosp Pharm; 1995 Apr; 30(4):287-90. PubMed ID: 10141869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of pharmacoeconomics to formulary management in a health system setting.
    Studdert AL; Gong CL; Srinivas S; Chin AL; Deresinski S
    Am J Health Syst Pharm; 2019 Feb; 76(6):381-386. PubMed ID: 31361838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulary Management Activities and Practice Implications Among Public Sector Hospital Pharmaceutical and Therapeutics Committees in a South African Province.
    Matlala M; Gous AGS; Meyer JC; Godman B
    Front Pharmacol; 2020; 11():1267. PubMed ID: 32973508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tri-hospital formulary management: a joint effort to standardize therapy and reduce costs.
    Kile DM; McGrath ME; Schindel LP
    Hosp Formul; 1987 Feb; 22(2):176, 178, 181. PubMed ID: 10280289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacoeconomics and formulary decision making.
    Sanchez LA
    Pharmacoeconomics; 1996; 9 Suppl 1():16-25. PubMed ID: 10160112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulary compliance and pharmacy labor costs associated with systematic formulary management strategy.
    Helmons PJ; Kosterink JG; Daniels CE
    Am J Health Syst Pharm; 2014 Mar; 71(5):407-15. PubMed ID: 24534596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.